前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201802261922101319
整理番号：18A0158518
TET2損失およびNRAS変異による協同的後成的リモデリング骨髄形質転換およびMEK阻害剤感受性を促進する【Powered by NICT】
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity
Kunimoto Hiroyoshi
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Kunimoto Hiroyoshi
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Kunimoto Hiroyoshi
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Meydan Cem
(Institute for Computational Biomedicine and Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA)
,
Nazir Abbas
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Nazir Abbas
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Nazir Abbas
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Whitfield Justin
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Whitfield Justin
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Whitfield Justin
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shank Kaitlyn
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shank Kaitlyn
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shank Kaitlyn
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Rapaport Franck
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Rapaport Franck
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Maher Rebecca
(University of Connecticut School of Medicine, Farmington, CT 06032, USA)
,
Pronier Elodie
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Pronier Elodie
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Pronier Elodie
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Meyer Sara C.
(Division of Hematology, University Hospital Basel, 4031 Basel, Switzerland)
,
Meyer Sara C.
(Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland)
,
Garrett-Bakelman Francine E.
(Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY 10065, USA)
,
Garrett-Bakelman Francine E.
(Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA)
,
Garrett-Bakelman Francine E.
(Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA)
,
Tallman Martin
(Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Melnick Ari
(Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY 10065, USA)
,
Melnick Ari
(Department of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA)
,
Levine Ross L.
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Levine Ross L.
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Levine Ross L.
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Levine Ross L.
(Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
,
Shih Alan H.
(Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA)
資料名：
Cancer Cell
(Cancer Cell)
巻： 33 号： 1 ページ： 44-59.e8 発行年： 2018年
JST資料番号： W1844A ISSN： 1535-6108 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： オランダ (NLD) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。